Enzymatica AB (publ) (STO:ENZY)
1.930
-0.070 (-3.50%)
Oct 31, 2025, 12:18 PM CET
Enzymatica AB Market Cap
Enzymatica AB has a market cap or net worth of 468.48 million as of October 31, 2025. Its market cap has increased by 46.85% in one year.
Market Cap
468.48M
Enterprise Value
436.70M
Revenue
52.73M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.93
Market Cap Chart
Since June 14, 2011, Enzymatica AB's market cap has increased from 108.93M to 468.48M, an increase of 330.08%. That is a compound annual growth rate of 10.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 468.48M | 37.42% |
| Dec 30, 2024 | 340.92M | -47.39% |
| Dec 29, 2023 | 647.99M | -12.33% |
| Dec 30, 2022 | 739.16M | -43.36% |
| Dec 30, 2021 | 1.31B | -51.13% |
| Dec 30, 2020 | 2.67B | 371.03% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 112.77B |
| Getinge AB | 60.82B |
| Sectra AB | 58.15B |
| Medicover AB | 39.10B |
| Camurus AB | 37.23B |
| Asker Healthcare Group AB | 33.00B |
| BioArctic AB | 25.95B |
| AddLife AB | 25.03B |